Metric Finance
LearnFAQ
LearnFAQ

Learn / BLFS

NASDAQ: BLFS

Biolife Solutions (BLFS) stock, explained like you're 5

Biolife Solutions trades on the Nasdaq under the ticker BLFS. It is a small cap company in the medical instruments & supplies industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.

Ticker
BLFS
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical Instruments & Supplies
Size
Small cap, about 1.9 billion dollars

Is Biolife Solutions a small, medium or large cap company?

No. Biolife Solutions is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.9 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Biolife Solutions makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves BLFS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Can BioLife Solutions (BLFS) Justify Its Price On Future Cash Flow? (Yahoo Finance)
  • BIOLIFE SOLUTIONS INC SEC Filing (Oct 16, 2026) (Stock Titan)
  • BioLife Solutions, Inc. (NASDAQ:BLFS) Stock Has Consensus Target Price of $31.38 According to Brokerages (MarketBeat)
  • A Look at BioLife Solutions Inc (BLFS) After 3.5% Gain GF Val (GuruFocus)
  • BioLife Solutions Reports Second Quarter 2026 Financial Results (PR Newswire)

Follow BLFS in your daily brief

Each trading day at 5 PM ET we post what happened to Biolife Solutions and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow BLFS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Biolife Solutions stock

What does Biolife Solutions do?

Biolife Solutions trades on the Nasdaq under the ticker BLFS. It is a small cap company in the medical instruments & supplies industry, part of the healthcare sector, with a market value of about 1.9 billion dollars.

What is the ticker symbol for Biolife Solutions?

Biolife Solutions trades under the ticker BLFS on the Nasdaq.

What is Biolife Solutions's market cap?

Biolife Solutions is a small cap stock with a market cap of about 1.9 billion dollars.

How does Biolife Solutions make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves BLFS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow BLFS stock every day?

Add BLFS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow BLFS daily

A free brief on Biolife Solutions and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ISRG · Intuitive Surgical
  • LLY · ELI LILLY & Co
  • JNJ · Johnson & Johnson
  • ABBV · AbbVie

Similar stocks

  • ISRGIntuitive Surgical
  • LLYELI LILLY & Co
  • JNJJohnson & Johnson
  • ABBVAbbVie

Compare BLFS: BLFS vs ISRG, BLFS vs LLY, BLFS vs JNJ

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed